Intervention not reported
Adverse events report of adverse events · patients with treating strongyloides infection
The intervention showed no clear difference in adverse events report of adverse events (low certainty).
1 finding from 1 review
- Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection 2016 · Cochrane Headline outcomes onlyRR 0.8 [0.59, 1.09]4 studies · 518 participantsLow